Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) [Phase 3]

View source ↗

Summary

Phase 3 trial of Microbiota Restoration Therapy for recurrent Clostridioides difficile infection has completed, with results posted in August 2023. The study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Microbiota Restoration Therapy (RBX2660) (RBX2660)

Snippet

Sponsor: Rebiotix Inc. | Conditions: Clostridium Difficile Infection (CDI) | Phase 3 | Status: COMPLETED | Results posted: 2023-08-14